<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04386148</url>
  </required_header>
  <id_info>
    <org_study_id>Obsidian-20</org_study_id>
    <nct_id>NCT04386148</nct_id>
  </id_info>
  <brief_title>Impact of Obsidian ® ASG on Anastomotic Healing</brief_title>
  <official_title>Impact of Obsidian® ASG Autologous Platelet-rich Fibrin Matrix on Anastomotic Healing in Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kepler University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kepler University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of regenerative medicine in colorectal surgery constitutes an entirely new
      therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic
      leak rate and minimise morbidity and mortality. The literature identifies the leak rate for
      colorectal operations as 3-39%.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction:

      The use of regenerative medicine in colorectal surgery constitutes an entirely new
      therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic
      leak rate and minimise morbidity and mortality. The literature identifies the leak rate for
      colorectal operations as 3-39%.

      Methods:

      This is a prospective, multi-centre descriptive study commencing in June 2018. As part of the
      elective laparoscopic colorectal surgery, an autologous fibrin matrix was used as part of
      anastomotic technique in conjunction with activated thrombocytes (Obsidian ASG®). During
      anastomosis, this matrix was applied after resection onto the colorectal tissue surfaces with
      the aim of triggering tissue regeneration and improved wound healing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic leak rate</measure>
    <time_frame>20 days</time_frame>
    <description>Anastomotic leak rate after colorectal surgery with Primary anastomosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>feacal blood</measure>
    <time_frame>20 days</time_frame>
    <description>feacal blood after colorectal surgery with Primary anastomosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fever</measure>
    <time_frame>20 days</time_frame>
    <description>fever higher than 38°C after colorectal surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of Hospital stay</measure>
    <time_frame>20 days</time_frame>
    <description>days spent in Hospital after undergoing colorectal surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">101</enrollment>
  <condition>Anastomotic Leak Rectum</condition>
  <arm_group>
    <arm_group_label>laparoscopic colorectal surgery</arm_group_label>
    <description>Patients undergoing laparoscopic colorectal surgery with use of Obsidian ASG® during primary anastomosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Obsidian ASG®</intervention_name>
    <description>As part of the elective laparoscopic colorectal surgery, an autologous fibrin matrix was used as part of anastomotic technique in conjunction with activated thrombocytes (Obsidian ASG®). During anastomosis, this matrix was applied after resection onto the colorectal tissue surfaces with the aim of triggering tissue regeneration and improved wound healing.</description>
    <arm_group_label>laparoscopic colorectal surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients who undergoing elective laparoscopic colorectal surgery with a primary left-sided
        anastomosis treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        elective laparoscopic colorectal surgery with a primary anastomosis treatment

        Exclusion Criteria:

          1. pregnancy

          2. Breastfeeding period

          3. concomitant disease with the potential for a relevant impairment of the anastomosis
             durability (leukemia, cirrhosis of the liver, Child Pugh A-C)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andreas Shamiyeh, Prof.Dr</last_name>
    <phone>+4357680832133</phone>
    <email>andreas.shamiyeh@kepleruniklinikum.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bettina Klugsberger, Dr</last_name>
    <phone>+43576808373031</phone>
    <email>bettina.klugsberger@kepleruniklinikum.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for General and Visceral Surgery, Kepler University Clinic Linz</name>
      <address>
        <city>Linz</city>
        <state>Upper Austria</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Shamiyeh, Prof. Dr.</last_name>
      <phone>+43 57680832133</phone>
      <email>andreas.shamiyeh@kepleruniklinikum.at</email>
    </contact>
    <contact_backup>
      <last_name>Bettina Klugsberger, Dr.</last_name>
      <phone>+43 576808373031</phone>
      <email>bettina.klugsberger@kepleruniklinikum.at</email>
    </contact_backup>
    <investigator>
      <last_name>Klugsberger Bettina, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Fraccalvieri D, Biondo S, Saez J, Millan M, Kreisler E, Golda T, Frago R, Miguel B. Management of colorectal anastomotic leakage: differences between salvage and anastomotic takedown. Am J Surg. 2012 Nov;204(5):671-6. doi: 10.1016/j.amjsurg.2010.04.022. Epub 2011 May 19.</citation>
    <PMID>21600561</PMID>
  </reference>
  <reference>
    <citation>Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, Laurberg S, den Dulk M, van de Velde C, Büchler MW. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010 Mar;147(3):339-51. doi: 10.1016/j.surg.2009.10.012. Epub 2009 Dec 11. Review.</citation>
    <PMID>20004450</PMID>
  </reference>
  <reference>
    <citation>Buchs NC, Gervaz P, Secic M, Bucher P, Mugnier-Konrad B, Morel P. Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study. Int J Colorectal Dis. 2008 Mar;23(3):265-70. Epub 2007 Nov 22.</citation>
    <PMID>18034250</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal surgery</keyword>
  <keyword>Anastomotic leak</keyword>
  <keyword>Obisidan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

